ID   PCCA_HUMAN              Reviewed;         728 AA.
AC   P05165; B4DKY8; B4DPF9; C9JPQ8; Q15979; Q8WXQ7;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 4.
DT   28-JUN-2023, entry version 244.
DE   RecName: Full=Propionyl-CoA carboxylase alpha chain, mitochondrial {ECO:0000305|PubMed:2740237};
DE            Short=PCCase subunit alpha;
DE            EC=6.4.1.3 {ECO:0000269|PubMed:6765947, ECO:0000269|PubMed:8434582};
DE   AltName: Full=Propanoyl-CoA:carbon dioxide ligase subunit alpha;
DE   Flags: Precursor;
GN   Name=PCCA {ECO:0000312|HGNC:HGNC:8653};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=11592820; DOI=10.1006/mgme.2001.3210;
RA   Campeau E., Desviat L.R., Leclerc D., Wu X., Perez B., Ugarte M.,
RA   Gravel R.A.;
RT   "Structure of the PCCA gene and distribution of mutations causing propionic
RT   acidemia.";
RL   Mol. Genet. Metab. 74:238-247(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Kidney, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-728 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-728 (ISOFORM 1).
RX   PubMed=2740237; DOI=10.1093/nar/17.11.4396;
RA   Lamhonwah A.-M., Mahuran D.J., Gravel R.A.;
RT   "Human mitochondrial propionyl-CoA carboxylase: localization of the N-
RT   terminus of the pro- and mature alpha chains in the deduced primary
RT   sequence of a full-length cDNA.";
RL   Nucleic Acids Res. 17:4396-4396(1989).
RN   [7]
RP   SEQUENCE REVISION.
RA   Gravel R.A.;
RL   Submitted (APR-1993) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PROTEIN SEQUENCE OF 53-58, AND SUBCELLULAR LOCATION.
RC   TISSUE=Kidney;
RX   PubMed=16023992; DOI=10.1016/j.bbrc.2005.06.190;
RA   Stadler S.C., Polanetz R., Meier S., Mayerhofer P.U., Herrmann J.M.,
RA   Anslinger K., Roscher A.A., Roschinger W., Holzinger A.;
RT   "Mitochondrial targeting signals and mature peptides of 3-methylcrotonyl-
RT   CoA carboxylase.";
RL   Biochem. Biophys. Res. Commun. 334:939-946(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 364-392, FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RC   TISSUE=Liver;
RX   PubMed=8434582;
RA   Stankovics J., Ledley F.D.;
RT   "Cloning of functional alpha propionyl CoA carboxylase and correction of
RT   enzyme deficiency in pccA fibroblasts.";
RL   Am. J. Hum. Genet. 52:144-151(1993).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 369-561.
RX   PubMed=3460076; DOI=10.1073/pnas.83.13.4864;
RA   Lamhonwah A.-M., Barankiewicz T.J., Willard H.F., Mahuran D.J., Quan F.,
RA   Gravel R.A.;
RT   "Isolation of cDNA clones coding for the alpha and beta chains of human
RT   propionyl-CoA carboxylase: chromosomal assignments and DNA polymorphisms
RT   associated with PCCA and PCCB genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:4864-4868(1986).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 633-728.
RX   PubMed=3555348; DOI=10.1016/0003-9861(87)90146-9;
RA   Lamhonwah A.-M., Quan F., Gravel R.A.;
RT   "Sequence homology around the biotin-binding site of human propionyl-CoA
RT   carboxylase and pyruvate carboxylase.";
RL   Arch. Biochem. Biophys. 254:631-636(1987).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, PATHWAY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND SUBUNIT.
RX   PubMed=6765947; DOI=10.1016/s0021-9258(19)86263-4;
RA   Kalousek F., Darigo M.D., Rosenberg L.E.;
RT   "Isolation and characterization of propionyl-CoA carboxylase from normal
RT   human liver. Evidence for a protomeric tetramer of nonidentical subunits.";
RL   J. Biol. Chem. 255:60-65(1980).
RN   [13]
RP   BIOTINYLATION BY HLCS.
RX   PubMed=7753853; DOI=10.1073/pnas.92.10.4626;
RA   Leon-Del-Rio A., Leclerc D., Akerman B., Wakamatsu N., Gravel R.A.;
RT   "Isolation of a cDNA encoding human holocarboxylase synthetase by
RT   functional complementation of a biotin auxotroph of Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:4626-4630(1995).
RN   [14]
RP   SUBUNIT.
RX   PubMed=20725044; DOI=10.1038/nature09302;
RA   Huang C.S., Sadre-Bazzaz K., Shen Y., Deng B., Zhou Z.H., Tong L.;
RT   "Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme
RT   A carboxylase.";
RL   Nature 466:1001-1005(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   INTERACTION WITH SIRT4; SIRT3 AND SIRT5.
RX   PubMed=23438705; DOI=10.1016/j.mito.2013.02.002;
RA   Wirth M., Karaca S., Wenzel D., Ho L., Tishkoff D., Lombard D.B.,
RA   Verdin E., Urlaub H., Jedrusik-Bode M., Fischle W.;
RT   "Mitochondrial SIRT4-type proteins in Caenorhabditis elegans and mammals
RT   interact with pyruvate carboxylase and other acetylated biotin-dependent
RT   carboxylases.";
RL   Mitochondrion 13:705-720(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   STRUCTURE BY NMR OF 175-270.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of B domain from human propionyl-CoA carboxylase alpha
RT   subunit.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 658-728, AND BIOTINYLATION AT
RP   LYS-694 BY HLCS.
RX   PubMed=20443544; DOI=10.1021/bi901612y;
RA   Healy S., McDonald M.K., Wu X., Yue W.W., Kochan G., Oppermann U.,
RA   Gravel R.A.;
RT   "Structural impact of human and Escherichia coli biotin carboxyl carrier
RT   proteins on biotin attachment.";
RL   Biochemistry 49:4687-4694(2010).
RN   [20]
RP   REVIEW ON PA VARIANTS.
RX   PubMed=10502773;
RX   DOI=10.1002/(sici)1098-1004(199910)14:4<275::aid-humu1>3.0.co;2-n;
RA   Ugarte M., Perez-Cerda C., Rodriguez-Pombo P., Desviat L.R., Perez B.,
RA   Richard E., Muro S., Campeau E., Ohura T., Gravel R.A.;
RT   "Overview of mutations in the PCCA and PCCB genes causing propionic
RT   acidemia.";
RL   Hum. Mutat. 14:275-282(1999).
RN   [21]
RP   VARIANTS PA-1 TRP-77; THR-138; THR-164; LYS-373 AND ARG-631,
RP   CHARACTERIZATION OF VARIANTS PA-1 TRP-77; THR-138; THR-164; LYS-373 AND
RP   ARG-631, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10101253; DOI=10.1016/s0925-4439(99)00008-3;
RA   Richard E., Desviat L.R., Perez B., Perez-Cerda C., Ugarte M.;
RT   "Genetic heterogeneity in propionic acidemia patients with alpha-subunit
RT   defects: identification of five novel mutations, one of them causing
RT   instability of the protein.";
RL   Biochim. Biophys. Acta 1453:351-358(1999).
RN   [22]
RP   VARIANT PHE-551, AND VARIANT PA-1 LEU-532 DEL.
RX   PubMed=12559849; DOI=10.1016/s1096-7192(02)00197-x;
RA   Perez B., Desviat L.R., Rodriguez-Pombo P., Clavero S., Navarrete R.,
RA   Perez-Cerda C., Ugarte M.;
RT   "Propionic acidemia: identification of twenty-four novel mutations in
RT   Europe and North America.";
RL   Mol. Genet. Metab. 78:59-67(2003).
RN   [23]
RP   VARIANTS PA-1 TRP-77; GLU-197; ARG-297; ARG-398; GLN-399; LEU-423 AND
RP   LEU-559.
RX   PubMed=15059621; DOI=10.1016/j.ymgme.2004.01.003;
RA   Yang X., Sakamoto O., Matsubara Y., Kure S., Suzuki Y., Aoki Y.,
RA   Yamaguchi S., Takahashi Y., Nishikubo T., Kawaguchi C., Yoshioka A.,
RA   Kimura T., Hayasaka K., Kohno Y., Iinuma K., Ohura T.;
RT   "Mutation spectrum of the PCCA and PCCB genes in Japanese patients with
RT   propionic acidemia.";
RL   Mol. Genet. Metab. 81:335-342(2004).
RN   [24]
RP   VARIANTS PA-1 PRO-75; LYS-229; GLY-368; VAL-379; ARG-668 AND CYS-712 DEL,
RP   CHARACTERIZATION OF VARIANTS PA-1 ARG-668 AND CYS-712 DEL, DOMAIN, AND
RP   BIOTINYLATION.
RX   PubMed=10329019; DOI=10.1006/mgme.1999.2850;
RA   Campeau E., Dupuis L., Leon-Del-Rio A., Gravel R.;
RT   "Coding sequence mutations in the alpha subunit of propionyl-CoA
RT   carboxylase in patients with propionic acidemia.";
RL   Mol. Genet. Metab. 67:11-22(1999).
CC   -!- FUNCTION: This is one of the 2 subunits of the biotin-dependent
CC       propionyl-CoA carboxylase (PCC), a mitochondrial enzyme involved in the
CC       catabolism of odd chain fatty acids, branched-chain amino acids
CC       isoleucine, threonine, methionine, and valine and other metabolites
CC       (PubMed:8434582, PubMed:6765947). Propionyl-CoA carboxylase catalyzes
CC       the carboxylation of propionyl-CoA/propanoyl-CoA to D-methylmalonyl-
CC       CoA/(S)-methylmalonyl-CoA (PubMed:8434582, PubMed:6765947,
CC       PubMed:10101253). Within the holoenzyme, the alpha subunit catalyzes
CC       the ATP-dependent carboxylation of the biotin carried by the biotin
CC       carboxyl carrier (BCC) domain, while the beta subunit then transfers
CC       the carboxyl group from carboxylated biotin to propionyl-CoA (By
CC       similarity). Propionyl-CoA carboxylase also significantly acts on
CC       butyryl-CoA/butanoyl-CoA, which is converted to ethylmalonyl-CoA/(2S)-
CC       ethylmalonyl-CoA at a much lower rate (PubMed:6765947). Other
CC       alternative minor substrates include (2E)-butenoyl-CoA/crotonoyl-CoA
CC       (By similarity). {ECO:0000250|UniProtKB:P0DTA4,
CC       ECO:0000250|UniProtKB:Q5LUF3, ECO:0000269|PubMed:10101253,
CC       ECO:0000269|PubMed:6765947, ECO:0000269|PubMed:8434582}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + hydrogencarbonate + propanoyl-CoA = (S)-methylmalonyl-
CC         CoA + ADP + H(+) + phosphate; Xref=Rhea:RHEA:23720,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17544, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57327, ChEBI:CHEBI:57392,
CC         ChEBI:CHEBI:456216; EC=6.4.1.3; Evidence={ECO:0000269|PubMed:6765947,
CC         ECO:0000269|PubMed:8434582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23721;
CC         Evidence={ECO:0000269|PubMed:6765947, ECO:0000269|PubMed:8434582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + butanoyl-CoA + hydrogencarbonate = (2S)-ethylmalonyl-CoA
CC         + ADP + H(+) + phosphate; Xref=Rhea:RHEA:59520, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17544, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57371, ChEBI:CHEBI:60909, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P0DTA4};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59521;
CC         Evidence={ECO:0000250|UniProtKB:P0DTA4};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00409};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00409};
CC       Note=Binds 2 magnesium or manganese ions per subunit.
CC       {ECO:0000255|PROSITE-ProRule:PRU00409};
CC   -!- COFACTOR:
CC       Name=biotin; Xref=ChEBI:CHEBI:57586; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU01066, ECO:0000269|PubMed:6765947};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.08 mM for ATP {ECO:0000269|PubMed:6765947};
CC         KM=3 mM for hydrogencarbonate {ECO:0000269|PubMed:6765947};
CC       pH dependence:
CC         Optimum pH is 7.2-8.8 for the propionyl-CoA carboxylase activity
CC         measured for the holoenzyme. {ECO:0000269|PubMed:6765947};
CC   -!- PATHWAY: Metabolic intermediate metabolism; propanoyl-CoA degradation;
CC       succinyl-CoA from propanoyl-CoA: step 1/3. {ECO:0000269|PubMed:6765947,
CC       ECO:0000269|PubMed:8434582}.
CC   -!- SUBUNIT: The holoenzyme is a dodecamer composed of 6 PCCA/alpha
CC       subunits and 6 PCCB/beta subunits (PubMed:6765947, PubMed:20725044).
CC       Interacts (via the biotin carboxylation domain) with SIRT4
CC       (PubMed:23438705). Interacts with SIRT3 and SIRT5 (PubMed:23438705).
CC       {ECO:0000269|PubMed:20725044, ECO:0000269|PubMed:23438705,
CC       ECO:0000269|PubMed:6765947, ECO:0000305}.
CC   -!- INTERACTION:
CC       P05165; P23508: MCC; NbExp=3; IntAct=EBI-2211679, EBI-307531;
CC       P05165; P05166: PCCB; NbExp=3; IntAct=EBI-2211679, EBI-1371908;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:10101253, ECO:0000269|PubMed:16023992}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P05165-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05165-2; Sequence=VSP_039857;
CC       Name=3;
CC         IsoId=P05165-3; Sequence=VSP_044458;
CC   -!- DOMAIN: Consists of an N-terminal biotin carboxylation/carboxylase (BC)
CC       domain that catalyzes the transient carboxylation of the biotin
CC       covalently attached to the C-terminal biotinyl-binding/biotin carboxyl
CC       carrier (BCC) domain. {ECO:0000305|PubMed:10329019}.
CC   -!- PTM: Acetylated. {ECO:0000250|UniProtKB:Q91ZA3}.
CC   -!- PTM: The biotin cofactor is covalently attached to the C-terminal
CC       biotinyl-binding domain and is required for the catalytic activity
CC       (PubMed:10329019). Biotinylation is catalyzed by HLCS (PubMed:7753853,
CC       PubMed:20443544). {ECO:0000269|PubMed:10329019,
CC       ECO:0000269|PubMed:20443544, ECO:0000269|PubMed:7753853}.
CC   -!- DISEASE: Propionic acidemia type I (PA-1) [MIM:606054]: Life-
CC       threatening disease characterized by episodic vomiting, lethargy and
CC       ketosis, neutropenia, periodic thrombocytopenia, hypogammaglobulinemia,
CC       developmental retardation, and intolerance to protein.
CC       {ECO:0000269|PubMed:10101253, ECO:0000269|PubMed:10329019,
CC       ECO:0000269|PubMed:12559849, ECO:0000269|PubMed:15059621}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA60035.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH00140.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAK61392.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA32763.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF385926; AAL66189.1; -; mRNA.
DR   EMBL; AY035808; AAK61392.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY035786; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035787; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035788; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035789; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035790; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035791; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035792; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035793; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035794; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035795; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035796; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035797; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035798; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035799; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035800; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035801; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035802; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035803; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035804; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035805; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035806; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AY035807; AAK61392.1; JOINED; Genomic_DNA.
DR   EMBL; AK296771; BAG59350.1; -; mRNA.
DR   EMBL; AK298318; BAG60571.1; -; mRNA.
DR   EMBL; AL355338; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356575; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136526; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353697; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471085; EAX09034.1; -; Genomic_DNA.
DR   EMBL; BC000140; AAH00140.1; ALT_INIT; mRNA.
DR   EMBL; X14608; CAA32763.1; ALT_FRAME; mRNA.
DR   EMBL; S55656; AAB25345.1; -; mRNA.
DR   EMBL; M13572; AAA60035.1; ALT_FRAME; mRNA.
DR   EMBL; M26121; AAA36424.1; -; mRNA.
DR   CCDS; CCDS45065.1; -. [P05165-2]
DR   CCDS; CCDS53878.1; -. [P05165-3]
DR   CCDS; CCDS9496.2; -. [P05165-1]
DR   PIR; S04613; A27883.
DR   RefSeq; NP_000273.2; NM_000282.3. [P05165-1]
DR   RefSeq; NP_001121164.1; NM_001127692.2. [P05165-2]
DR   RefSeq; NP_001171475.1; NM_001178004.1. [P05165-3]
DR   PDB; 2CQY; NMR; -; A=176-270.
DR   PDB; 2JKU; X-ray; 1.50 A; A=658-728.
DR   PDBsum; 2CQY; -.
DR   PDBsum; 2JKU; -.
DR   AlphaFoldDB; P05165; -.
DR   SMR; P05165; -.
DR   BioGRID; 111128; 135.
DR   ComplexPortal; CPX-6169; Mitochondrial propionyl-CoA carboxylase complex.
DR   CORUM; P05165; -.
DR   DIP; DIP-57493N; -.
DR   IntAct; P05165; 33.
DR   MINT; P05165; -.
DR   STRING; 9606.ENSP00000365462; -.
DR   DrugBank; DB00121; Biotin.
DR   GlyGen; P05165; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; P05165; -.
DR   PhosphoSitePlus; P05165; -.
DR   SwissPalm; P05165; -.
DR   BioMuta; PCCA; -.
DR   DMDM; 308153661; -.
DR   EPD; P05165; -.
DR   jPOST; P05165; -.
DR   MassIVE; P05165; -.
DR   MaxQB; P05165; -.
DR   PaxDb; P05165; -.
DR   PeptideAtlas; P05165; -.
DR   ProteomicsDB; 11147; -.
DR   ProteomicsDB; 51814; -. [P05165-1]
DR   ProteomicsDB; 51815; -. [P05165-2]
DR   Antibodypedia; 25211; 217 antibodies from 27 providers.
DR   DNASU; 5095; -.
DR   Ensembl; ENST00000376279.7; ENSP00000365456.3; ENSG00000175198.17. [P05165-3]
DR   Ensembl; ENST00000376285.6; ENSP00000365462.1; ENSG00000175198.17. [P05165-1]
DR   Ensembl; ENST00000376286.8; ENSP00000365463.4; ENSG00000175198.17. [P05165-2]
DR   GeneID; 5095; -.
DR   KEGG; hsa:5095; -.
DR   MANE-Select; ENST00000376285.6; ENSP00000365462.1; NM_000282.4; NP_000273.2.
DR   UCSC; uc001voo.4; human. [P05165-1]
DR   AGR; HGNC:8653; -.
DR   CTD; 5095; -.
DR   DisGeNET; 5095; -.
DR   GeneCards; PCCA; -.
DR   GeneReviews; PCCA; -.
DR   HGNC; HGNC:8653; PCCA.
DR   HPA; ENSG00000175198; Tissue enhanced (epididymis).
DR   MalaCards; PCCA; -.
DR   MIM; 232000; gene.
DR   MIM; 606054; phenotype.
DR   neXtProt; NX_P05165; -.
DR   OpenTargets; ENSG00000175198; -.
DR   Orphanet; 35; Propionic acidemia.
DR   PharmGKB; PA32992; -.
DR   VEuPathDB; HostDB:ENSG00000175198; -.
DR   eggNOG; KOG0238; Eukaryota.
DR   GeneTree; ENSGT00940000156083; -.
DR   HOGENOM; CLU_000395_3_3_1; -.
DR   InParanoid; P05165; -.
DR   OMA; MYYDSMI; -.
DR   OrthoDB; 1129179at2759; -.
DR   PhylomeDB; P05165; -.
DR   TreeFam; TF354220; -.
DR   BioCyc; MetaCyc:ENSG00000175198-MON; -.
DR   BRENDA; 6.4.1.3; 2681.
DR   PathwayCommons; P05165; -.
DR   Reactome; R-HSA-196780; Biotin transport and metabolism.
DR   Reactome; R-HSA-3371599; Defective HLCS causes multiple carboxylase deficiency.
DR   Reactome; R-HSA-71032; Propionyl-CoA catabolism.
DR   SABIO-RK; P05165; -.
DR   SignaLink; P05165; -.
DR   SIGNOR; P05165; -.
DR   UniPathway; UPA00945; UER00908.
DR   BioGRID-ORCS; 5095; 14 hits in 1151 CRISPR screens.
DR   ChiTaRS; PCCA; human.
DR   EvolutionaryTrace; P05165; -.
DR   GenomeRNAi; 5095; -.
DR   Pharos; P05165; Tbio.
DR   PRO; PR:P05165; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; P05165; protein.
DR   Bgee; ENSG00000175198; Expressed in right lobe of liver and 198 other tissues.
DR   ExpressionAtlas; P05165; baseline and differential.
DR   Genevisible; P05165; HS.
DR   GO; GO:1902494; C:catalytic complex; IPI:ComplexPortal.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0009374; F:biotin binding; TAS:ProtInc.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004658; F:propionyl-CoA carboxylase activity; IDA:UniProtKB.
DR   GO; GO:0009081; P:branched-chain amino acid metabolic process; NAS:ComplexPortal.
DR   GO; GO:0006631; P:fatty acid metabolic process; NAS:ComplexPortal.
DR   GO; GO:0019626; P:short-chain fatty acid catabolic process; IC:UniProtKB.
DR   CDD; cd06850; biotinyl_domain; 1.
DR   Gene3D; 2.40.50.100; -; 1.
DR   Gene3D; 3.30.700.30; -; 1.
DR   Gene3D; 3.40.50.20; -; 1.
DR   Gene3D; 3.30.1490.20; ATP-grasp fold, A domain; 1.
DR   Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1.
DR   InterPro; IPR011761; ATP-grasp.
DR   InterPro; IPR013815; ATP_grasp_subdomain_1.
DR   InterPro; IPR005481; BC-like_N.
DR   InterPro; IPR001882; Biotin_BS.
DR   InterPro; IPR011764; Biotin_carboxylation_dom.
DR   InterPro; IPR005482; Biotin_COase_C.
DR   InterPro; IPR000089; Biotin_lipoyl.
DR   InterPro; IPR005479; CbamoylP_synth_lsu-like_ATP-bd.
DR   InterPro; IPR041265; PCC_BT.
DR   InterPro; IPR016185; PreATP-grasp_dom_sf.
DR   InterPro; IPR011054; Rudment_hybrid_motif.
DR   InterPro; IPR011053; Single_hybrid_motif.
DR   PANTHER; PTHR18866; CARBOXYLASE:PYRUVATE/ACETYL-COA/PROPIONYL-COA CARBOXYLASE; 1.
DR   PANTHER; PTHR18866:SF33; METHYLCROTONOYL-COA CARBOXYLASE SUBUNIT ALPHA, MITOCHONDRIAL-RELATED; 1.
DR   Pfam; PF02785; Biotin_carb_C; 1.
DR   Pfam; PF00289; Biotin_carb_N; 1.
DR   Pfam; PF00364; Biotin_lipoyl; 1.
DR   Pfam; PF02786; CPSase_L_D2; 1.
DR   Pfam; PF18140; PCC_BT; 1.
DR   SMART; SM00878; Biotin_carb_C; 1.
DR   SUPFAM; SSF56059; Glutathione synthetase ATP-binding domain-like; 1.
DR   SUPFAM; SSF52440; PreATP-grasp domain; 1.
DR   SUPFAM; SSF51246; Rudiment single hybrid motif; 1.
DR   SUPFAM; SSF51230; Single hybrid motif; 1.
DR   PROSITE; PS50975; ATP_GRASP; 1.
DR   PROSITE; PS50979; BC; 1.
DR   PROSITE; PS00188; BIOTIN; 1.
DR   PROSITE; PS50968; BIOTINYL_LIPOYL; 1.
DR   PROSITE; PS00866; CPSASE_1; 1.
DR   PROSITE; PS00867; CPSASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Biotin;
KW   Direct protein sequencing; Disease variant; Ligase; Lipid degradation;
KW   Lipid metabolism; Magnesium; Manganese; Metal-binding; Mitochondrion;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transit peptide.
FT   TRANSIT         1..52
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:16023992"
FT   CHAIN           53..728
FT                   /note="Propionyl-CoA carboxylase alpha chain,
FT                   mitochondrial"
FT                   /id="PRO_0000002837"
FT   DOMAIN          62..509
FT                   /note="Biotin carboxylation"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00969"
FT   DOMAIN          181..378
FT                   /note="ATP-grasp"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   DOMAIN          653..728
FT                   /note="Biotinyl-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01066"
FT   ACT_SITE        349
FT                   /evidence="ECO:0000250"
FT   BINDING         177
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         209..270
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         261
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         296
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         336
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         336
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         349
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         349
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         349
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         349
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         351
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         351
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         409
FT                   /ligand="biotin"
FT                   /ligand_id="ChEBI:CHEBI:57586"
FT                   /evidence="ECO:0000250|UniProtKB:Q5LUF3"
FT   MOD_RES         65
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         65
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         119
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         150
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         150
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         200
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         200
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         262
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         328
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         328
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         385
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         407
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         496
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         502
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         513
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         648
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZA3"
FT   MOD_RES         694
FT                   /note="N6-biotinyllysine; by HLCS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01066,
FT                   ECO:0000269|PubMed:20443544"
FT   VAR_SEQ         36..61
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_039857"
FT   VAR_SEQ         634..680
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044458"
FT   VARIANT         75
FT                   /note="A -> P (in PA-1; dbSNP:rs794727479)"
FT                   /evidence="ECO:0000269|PubMed:10329019"
FT                   /id="VAR_009087"
FT   VARIANT         77
FT                   /note="R -> W (in PA-1; loss of function;
FT                   dbSNP:rs141371306)"
FT                   /evidence="ECO:0000269|PubMed:10101253,
FT                   ECO:0000269|PubMed:15059621"
FT                   /id="VAR_009088"
FT   VARIANT         138
FT                   /note="A -> T (in PA-1; loss of function;
FT                   dbSNP:rs202247814)"
FT                   /evidence="ECO:0000269|PubMed:10101253"
FT                   /id="VAR_009089"
FT   VARIANT         164
FT                   /note="I -> T (in PA-1; loss of function;
FT                   dbSNP:rs202247815)"
FT                   /evidence="ECO:0000269|PubMed:10101253"
FT                   /id="VAR_009090"
FT   VARIANT         197
FT                   /note="G -> E (in PA-1)"
FT                   /evidence="ECO:0000269|PubMed:15059621"
FT                   /id="VAR_023843"
FT   VARIANT         229
FT                   /note="M -> K (in PA-1; dbSNP:rs375628794)"
FT                   /evidence="ECO:0000269|PubMed:10329019"
FT                   /id="VAR_009091"
FT   VARIANT         297
FT                   /note="Q -> R (in PA-1)"
FT                   /evidence="ECO:0000269|PubMed:15059621"
FT                   /id="VAR_009092"
FT   VARIANT         368
FT                   /note="D -> G (in PA-1)"
FT                   /evidence="ECO:0000269|PubMed:10329019"
FT                   /id="VAR_009093"
FT   VARIANT         373
FT                   /note="M -> K (in PA-1; unstable protein; loss of function;
FT                   dbSNP:rs121964958)"
FT                   /evidence="ECO:0000269|PubMed:10101253"
FT                   /id="VAR_009094"
FT   VARIANT         379
FT                   /note="G -> V (in PA-1; dbSNP:rs794727087)"
FT                   /evidence="ECO:0000269|PubMed:10329019"
FT                   /id="VAR_009095"
FT   VARIANT         398
FT                   /note="C -> R (in PA-1)"
FT                   /evidence="ECO:0000269|PubMed:15059621"
FT                   /id="VAR_023844"
FT   VARIANT         399
FT                   /note="R -> Q (in PA-1; dbSNP:rs1301904623)"
FT                   /evidence="ECO:0000269|PubMed:15059621"
FT                   /id="VAR_009096"
FT   VARIANT         423
FT                   /note="P -> L (in PA-1; dbSNP:rs1443858896)"
FT                   /evidence="ECO:0000269|PubMed:15059621"
FT                   /id="VAR_009097"
FT   VARIANT         475
FT                   /note="I -> V (in dbSNP:rs35719359)"
FT                   /id="VAR_009098"
FT   VARIANT         532
FT                   /note="Missing (in PA-1)"
FT                   /evidence="ECO:0000269|PubMed:12559849"
FT                   /id="VAR_023845"
FT   VARIANT         551
FT                   /note="V -> F (in dbSNP:rs61749895)"
FT                   /evidence="ECO:0000269|PubMed:12559849"
FT                   /id="VAR_023846"
FT   VARIANT         559
FT                   /note="W -> L (in PA-1; dbSNP:rs118169528)"
FT                   /evidence="ECO:0000269|PubMed:15059621"
FT                   /id="VAR_009099"
FT   VARIANT         631
FT                   /note="G -> R (in PA-1; loss of function;
FT                   dbSNP:rs796052018)"
FT                   /evidence="ECO:0000269|PubMed:10101253"
FT                   /id="VAR_009100"
FT   VARIANT         668
FT                   /note="G -> R (in PA-1; loss of biotinylation;
FT                   dbSNP:rs771438170)"
FT                   /evidence="ECO:0000269|PubMed:10329019"
FT                   /id="VAR_009101"
FT   VARIANT         712
FT                   /note="Missing (in PA-1; loss of biotinylation)"
FT                   /evidence="ECO:0000269|PubMed:10329019"
FT                   /id="VAR_009102"
FT   CONFLICT        61
FT                   /note="K -> E (in Ref. 2; BAG60571)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        93
FT                   /note="H -> Y (in Ref. 4; BAG59350)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        373
FT                   /note="M -> R (in Ref. 10; AAA60035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        378..379
FT                   /note="KG -> RS (in Ref. 10; AAA60035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        558
FT                   /note="N -> H (in Ref. 10; AAA60035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        610
FT                   /note="T -> A (in Ref. 4; BAG59350)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        679
FT                   /note="D -> A (in Ref. 11; AAA36424)"
FT                   /evidence="ECO:0000305"
FT   STRAND          199..201
FT                   /evidence="ECO:0007829|PDB:2CQY"
FT   HELIX           202..212
FT                   /evidence="ECO:0007829|PDB:2CQY"
FT   STRAND          214..220
FT                   /evidence="ECO:0007829|PDB:2CQY"
FT   TURN            226..228
FT                   /evidence="ECO:0007829|PDB:2CQY"
FT   STRAND          230..234
FT                   /evidence="ECO:0007829|PDB:2CQY"
FT   HELIX           235..252
FT                   /evidence="ECO:0007829|PDB:2CQY"
FT   STRAND          258..262
FT                   /evidence="ECO:0007829|PDB:2CQY"
FT   STRAND          265..268
FT                   /evidence="ECO:0007829|PDB:2CQY"
FT   STRAND          665..667
FT                   /evidence="ECO:0007829|PDB:2JKU"
FT   STRAND          669..673
FT                   /evidence="ECO:0007829|PDB:2JKU"
FT   STRAND          688..691
FT                   /evidence="ECO:0007829|PDB:2JKU"
SQ   SEQUENCE   728 AA;  80059 MW;  065F64186A0B8CCC CRC64;
     MAGFWVGTAP LVAAGRRGRW PPQQLMLSAA LRTLKHVLYY SRQCLMVSRN LGSVGYDPNE
     KTFDKILVAN RGEIACRVIR TCKKMGIKTV AIHSDVDASS VHVKMADEAV CVGPAPTSKS
     YLNMDAIMEA IKKTRAQAVH PGYGFLSENK EFARCLAAED VVFIGPDTHA IQAMGDKIES
     KLLAKKAEVN TIPGFDGVVK DAEEAVRIAR EIGYPVMIKA SAGGGGKGMR IAWDDEETRD
     GFRLSSQEAA SSFGDDRLLI EKFIDNPRHI EIQVLGDKHG NALWLNEREC SIQRRNQKVV
     EEAPSIFLDA ETRRAMGEQA VALARAVKYS SAGTVEFLVD SKKNFYFLEM NTRLQVEHPV
     TECITGLDLV QEMIRVAKGY PLRHKQADIR INGWAVECRV YAEDPYKSFG LPSIGRLSQY
     QEPLHLPGVR VDSGIQPGSD ISIYYDPMIS KLITYGSDRT EALKRMADAL DNYVIRGVTH
     NIALLREVII NSRFVKGDIS TKFLSDVYPD GFKGHMLTKS EKNQLLAIAS SLFVAFQLRA
     QHFQENSRMP VIKPDIANWE LSVKLHDKVH TVVASNNGSV FSVEVDGSKL NVTSTWNLAS
     PLLSVSVDGT QRTVQCLSRE AGGNMSIQFL GTVYKVNILT RLAAELNKFM LEKVTEDTSS
     VLRSPMPGVV VAVSVKPGDA VAEGQEICVI EAMKMQNSMT AGKTGTVKSV HCQAGDTVGE
     GDLLVELE
//
